Neuro-Behçet Disease and Autoinflammatory Disorders

Abstract

Misregulation of innate immunity leads to autoinflammation. Behçet disease is an autoinflammatory condition involving recurrent attacks of inflammation in skin, eyes, joints, and even the nervous system. The etiology may involve vascular inflammation. Central nervous system involvement in neuro-Behçet disease (NBD) comes in the form of parenchymal NBD or nonparenchymal NBD. The parenchymal form has a predilection for the brainstem, diencephalon and cerebral hemispheres, and represents a meningoencephalitis thought to be related to small vessel vasculitis. Cerebral venous sinus thrombosis, arising from a vasculitic process of large veins, comprises the majority of vascular NBD cases. The rarer monogenetic autoinflammatory syndromes are characterized by periodic fever, and typically present in the pediatric population. Neurologic involvement in these syndromes typically presents in the form of an aseptic meningitis. Treatment of autoinflammatory disorders involves immune modulation with corticosteroids, disease-modifying antirheumatic medications, and increasingly antibodies targeting cytokines like tumor necrosis factor α and interleukin 1.

Keywords

neuro-Behçet - autoinflammatory syndromes - neurologic disease - cerebral venous thrombosis - vasculitis

• References

• 1 Jorizzo JL, Abernethy JL, White WL , et al. Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995; 32 (6) 968-976
• 2 International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335 (8697) 1078-1080
• 3 Yazici H, Yurdakul S, Hamuryudan V. Behçet disease. Curr Opin Rheumatol 2001; 13 (1) 18-22
• 4 Siva A, Saip S. The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. J Neurol 2009; 256 (4) 513-529
• 5 Vural B, Sehitoğlu E, Cavuş F , et al. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease. J Neuroimmunol 2013; 263 (1-2) 139-144
• 6 Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 1997; 14 (1) 1-10
• 7 Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005; 4 (1) 81-83
• 8 Hedayatfar A. Behçet's disease: autoimmune or autoinflammatory?. J Ophthalmic Vis Res 2013; 8 (3) 291-293
• 9 Zhang M, Xu WD, Wen PF , et al. Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis. Mol Vis 2013; 19: 1913-1924
• 10 Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8 (2) 192-204
• 11 Akman-Demir G, Serdaroglu P, Tasçi B ; The Neuro-Behçet Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999; 122 (Pt 11) 2171-2182
• 12 Dutra LA, Gonçalves CR, Braga-Neto P , et al. Atypical manifestations in Brazilian patients with neuro-Behçet's disease. J Neurol 2012; 259 (6) 1159-1165
• 13 Riera-Mestre A, Martínez-Yelamos S, Martínez-Yelamos A, Ferrer I, Pujol R, Vidaller A. Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: a study of 20 patients. Eur J Intern Med 2010; 21 (6) 536-541
• 14 Lueck CJ, Pires M, McCartney AC, Graham EM. Ocular and neurological Behçet's disease without orogenital ulceration?. J Neurol Neurosurg Psychiatry 1993; 56 (5) 505-508
• 15 Al-Fahad SA, Al-Araji AH. Neuro-Behcet's disease in Iraq: a study of 40 patients. J Neurol Sci 1999; 170 (2) 105-111
• 16 Houman MH, Bellakhal S, Ben Salem T , et al. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia. Clin Neurol Neurosurg 2013; 115 (10) 2015-2018
• 17 Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet's syndrome. Brain 1999; 122 (Pt 11) 2183-2194
• 18 Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro-Behçet disease. A review. Neurologist 2005; 11 (2) 80-89
• 19 Aykutlu E, Baykan B, Serdaroglu P, Gökyigit A, Akman-Demir G. Epileptic seizures in Behçet disease. Epilepsia 2002; 43 (8) 832-835
• 20 Kansu T, Kadayifcilar S. Visual aspects of Behçet's disease. Curr Neurol Neurosci Rep 2005; 5 (5) 382-388
• 21 Saip S, Akman-Demir G, Siva A. Neuro-Behçet syndrome. In: Biller J, Ferro JM, , Eds. Handbook of Clinical Neurology. Vol. 121. Amsterdam: Elsevier; 2014: 1703-1723
• 22 Graham D, McCarthy A, Kavanagh E, O'Rourke K, Lynch T. Teaching NeuroImages: longitudinally extensive transverse myelitis in neuro-Behcet disease. Neurology 2013; 80 (18) e189-e190
• 23 Uygunoğlu U, Pasha M, Saip S, Siva A. Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab. J Spinal Cord Med 2014; ; epub ahead of print
• 24 Aguiar de Sousa D, Mestre T, Ferro JM. Cerebral venous thrombosis in Behçet's disease: a systematic review. J Neurol 2011; 258 (5) 719-727
• 25 Mohammed RH, Nasef A, Kewan HH, Al Shaar M. Vascular neurobehcet disease: correlation with current disease activity forum and systemic vascular involvement. Clin Rheumatol 2012; 31 (7) 1033-1040
• 26 Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3 (3) 148-155
• 27 de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61 (10) 1287-1296
• 28 Scully SE, Stebner FC, Yoest SM. Magnetic resonance spectroscopic findings in neuro-Behçet disease. Neurologist 2004; 10 (6) 323-326
• 29 Borhani Haghighi A, Sarhadi S, Farahangiz S. MRI findings of neuro-Behcet's disease. Clin Rheumatol 2011; 30 (6) 765-770
• 30 Baysal T, Dogan M, Karlidag R , et al. Diffusion-weighted imaging in chronic Behçet patients with and without neurological findings. Neuroradiology 2005; 47 (6) 431-437
• 31 Albayram S, Saip S, Hasiloglu ZI , et al. Evaluation of parenchymal neuro-behçet disease by using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2011; 32 (6) 1050-1055
• 32 Yesilot N, Bahar S, Yilmazer S , et al. Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies. J Neurol 2009; 256 (7) 1134-1142
• 33 Kalra S, Silman A, Akman-Demir G , et al. Diagnosis and management of neuro-Behçet's disease: international consensus recommendations. J Neurol 2013; ; epub ahead of print
• 34 Rubinstein LJ, Urich H. Meningo-encephalitis of Behcet's disease: case report with pathological findings. Brain 1963; 86: 151-160
• 35 Akman-Demir G, Saip S, Siva A. Behçet's Disease. Curr Treat Options Neurol 2011; 13 (3) 290-310
• 36 Borhani Haghighi A, Safari A. Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease. Clin Rheumatol 2010; 29 (6) 683-686
• 37 Noel N, Bernard R, Wechsler B , et al. Long-term outcome of neuro-Behçet's disease. Arthritis Rheum 2014; ; epub ahead of print
• 38 Li J, Fernando S, Herkes G. Use of infliximab and other biologics in Behçet disease. Intern Med J 2014; 44 (1) 96-100
• 39 Borhani Haghighi A, Safari A, Nazarinia MA, Habibagahi Z, Shenavandeh S. Infliximab for patients with neuro-Behcet's disease: case series and literature review. Clin Rheumatol 2011; 30 (7) 1007-1012
• 40 Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001; 345 (24) 1748-1757
• 41 Abramovits W, Oquendo M. Introduction to autoinflammatory syndromes and diseases. Dermatol Clin 2013; 31 (3) 363-385
• 42 Hashkes PJ, Toker O. Autoinflammatory syndromes. Pediatr Clin North Am 2012; 59 (2) 447-470
• 43 Touitou I, Galeotti C, Rossi-Semerano L, Hentgen V, Piram M, Koné-Paut I ; CeRéMAI, French reference center for autoinflammatory diseases. The expanding spectrum of rare monogenic autoinflammatory diseases. Orphanet J Rare Dis 2013; 8: 162
• 44 Theofilopoulos AN, Gonzalez-Quintial R, Lawson BR , et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat Rev Rheumatol 2010; 6 (3) 146-156
• 45 Caso F, Rigante D, Vitale A , et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol 2013; 2013: 513782
• 46 Neven B, Marvillet I, Terrada C , et al. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2010; 62 (1) 258-267
• 47 Karachaliou I, Karachalios G, Charalabopoulos A, Charalabopoulos K. Meningitis associated with familial Mediterranean fever. Int J Clin Pract Suppl 2005; 147 (147) 60-61
• 48 Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF: published and own experience. Best Pract Res Clin Rheumatol 2012; 26 (1) 119-133
• 49 Jesus AA, Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med 2014; 65: 223-244